Characterization of iPSC lines. Figure S1. Immunostaining of DIAN iPSCs for pluripotency markers. iPSCs included in the collection were fixed and stained with antibodies to OCT4 and TRA1. Scale bar represents 100 μm. Figure S2. Quantitative assessment of pluripotent markers in DIAN iPSCs. iPSCs lines were analyzed by qPCR (TaqMan assay) to determine expression of pluripotency markers and, in lines reprogrammed with Sendai virus, the absence of Sendai virus. Human embryonic stem cells (H9) were included as a positive control. Genes are expressed relative to a housekeeping gene, GAPDH. Graphs represent mean normalized expressed ± SEM. Figure S3. Karyotypes of DIAN iPSCs. G-band karyotyping of iPSCs exhibit no chromosomal abnormalities in the ...
Figure S1. Western blots of iPSC-derived basal cholinergic neuroprecursors cell lines. Cells were in...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Showing characterization of iPSCs derived from skin fibroblasts of a patient with hemoglobin E/beta-...
Virtual karyotyping of iPSC lines. Figure S4. Virtual karyotyping. (PDF 102140 kb
In vitro differentiation analysis and karyotyping of LiPSC. (A) Representative karyotype of the esta...
Analysis of premutation iPSCs and full mutation ESCs. a Immunostaining for pluripotency markers in S...
is Figure S1 showing cellular characteristics and HPC/HSC reprogramming. A Identification of HPC/HSC...
Table S1. List of primary MSC samples. Table S2. List of primers. Table S3. List of antibodies. Figu...
is Figure S3 showing mESCs express pluripotency genes. Immunofluorescence staining of mESCs using pl...
Additional file 3: Figure S3. Characterization of iPSC-derived NPCs from two other iPSC clonal lines...
Evaluation of hiPSCs, TIGE-9 and YFE-16 cells. a The genomic integration of episomal vectors was det...
is Figure S1 showing differentiation of hiPSCs into NPCs using commercial reagents. Two hiPSC lines ...
Figure S2 showing characterization of iPSC colony 5. a Karyotype of iPSC colony 5 was normal. b qRT-...
The induced pluripotent stem cell (iPSC) lines UOWi002-A and UOWi003-A were reprogrammed from dermal...
GFP expression by lenti-GFP-transduced hNSCs. Proliferating lenti-GFP-transduced hNSCs form neurosph...
Figure S1. Western blots of iPSC-derived basal cholinergic neuroprecursors cell lines. Cells were in...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Showing characterization of iPSCs derived from skin fibroblasts of a patient with hemoglobin E/beta-...
Virtual karyotyping of iPSC lines. Figure S4. Virtual karyotyping. (PDF 102140 kb
In vitro differentiation analysis and karyotyping of LiPSC. (A) Representative karyotype of the esta...
Analysis of premutation iPSCs and full mutation ESCs. a Immunostaining for pluripotency markers in S...
is Figure S1 showing cellular characteristics and HPC/HSC reprogramming. A Identification of HPC/HSC...
Table S1. List of primary MSC samples. Table S2. List of primers. Table S3. List of antibodies. Figu...
is Figure S3 showing mESCs express pluripotency genes. Immunofluorescence staining of mESCs using pl...
Additional file 3: Figure S3. Characterization of iPSC-derived NPCs from two other iPSC clonal lines...
Evaluation of hiPSCs, TIGE-9 and YFE-16 cells. a The genomic integration of episomal vectors was det...
is Figure S1 showing differentiation of hiPSCs into NPCs using commercial reagents. Two hiPSC lines ...
Figure S2 showing characterization of iPSC colony 5. a Karyotype of iPSC colony 5 was normal. b qRT-...
The induced pluripotent stem cell (iPSC) lines UOWi002-A and UOWi003-A were reprogrammed from dermal...
GFP expression by lenti-GFP-transduced hNSCs. Proliferating lenti-GFP-transduced hNSCs form neurosph...
Figure S1. Western blots of iPSC-derived basal cholinergic neuroprecursors cell lines. Cells were in...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Showing characterization of iPSCs derived from skin fibroblasts of a patient with hemoglobin E/beta-...